MIDDLETON, Wis., July 22, 2025 /PRNewswire/ -- Natus Medical Incorporated is continuing its commitment to innovation and expanding the functionality of one of its flagship products with the ...
MIDDLETON, Wis., May 20, 2025 /PRNewswire/ -- Natus Medical Incorporated has announced the official launch of BrainWatch™, the highly anticipated point-of-care EEG solution designed to bring the ...
MIDDLETON, Wis., Dec. 4, 2024 /PRNewswire/ -- Natus Medical Incorporated will debut its highly anticipated, FDA-cleared point-of-care EEG solution, BrainWatch™, during the American Epilepsy Society ...
A set of critical vulnerabilities have been uncovered in Natus NeuroWorks software which may place medical devices connecting to the software at risk. On Wednesday, researchers from Cisco Talos said ...
MIDDLETON, Wis., Oct. 10, 2024 /PRNewswire/ -- Natus Medical Incorporated announced it has submitted an FDA 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its Natus ...
MIDDLETON, Wis., March 5, 2026 /PRNewswire/ -- Natus Medical Incorporated has announced the global launch of the autoSCORE™ analysis tool, spreading the availability of the first ...